Publications (62) Publications in which a researcher has participated

2024

  1. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

    JHEP Reports, Vol. 6, Núm. 1

  2. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

    Gut Microbes, Vol. 16, Núm. 1

  3. Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th response

    Liver International, Vol. 44, Núm. 4, pp. 996-1010

  4. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network

    Journal of Hepatology, Vol. 81, Núm. 4, pp. 630-640

  5. Curcumin encapsulated in milk small extracellular vesicles as a nanotherapeutic alternative in experimental chronic liver disease

    Biomedicine and Pharmacotherapy, Vol. 173

  6. Drug-induced liver injury

    Sinusoidal Cells in Liver Diseases: Role in their Pathophysiology, Diagnosis, and Treatment (Elsevier Science Ltd.), pp. 193-212

  7. FTO/m6A/GPNMB axis: a novel promising target for hepatocellular carcinoma (HCC) treatment?

    Gut

  8. Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol

    Frontiers in Nutrition, Vol. 11

  9. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma

    Gut

  10. Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury

    Redox Biology, Vol. 71

  11. Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)

    Nature Communications, Vol. 15, Núm. 1

  12. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

  13. Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet

    Pharmacological Research, Vol. 200

  14. Seladelpar: New hope for patients with primary biliary cholangitis

    Med

  15. p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway

    Cell Reports Medicine, Vol. 5, Núm. 2

2023

  1. A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d

    Cancers, Vol. 15, Núm. 16

  2. Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism

    Gut

  3. Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice

    Cell Death and Disease, Vol. 14, Núm. 8

  4. Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress

    Frontiers in immunology, Vol. 14, pp. 1185517

  5. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming

    Journal of Hepatology, Vol. 79, Núm. 3, pp. 728-740